Pravastatin improves survival in cardiac transplant recipients
Pravastatin improves survival in cardiac transplant recipients
In a study of 97 heart transplant recipients randomly assigned to pravastatin or placebo, survival at one year was significantly better with pravastatin (94 versus 78 percent).
Data from Kobashigawa JA, Katznelson S, Laks H, et al. N Engl J Med 1995; 333:621.